PCN25 COST-EFFECTIVENESS OF NIVOLUMAB IN FIRST-LINE TREATMENT OF ADVANCED MELANOMA REGARDLESS OF BRAF MUTATION STATUS FROM A BRAZILIAN PUBLIC HEALTHCARE SYSTEM
Lima, J.P.D.S.N., Marinheiro, P., Bernardino, G.Volume:
19
Journal:
Value in Health Regional Issues
DOI:
10.1016/j.vhri.2019.08.093
Date:
October, 2019
File:
PDF, 592 KB
2019